Troubles du cycle veille/sommeil liés à la maladie de Parkinson : modèle animal, mécanismes et approches thérapeutiques

Troubles du cycle veille/sommeil liés à la maladie de Parkinson : modèle animal, mécanismes et approches thérapeutiques

Les troubles du sommeil, tels que la somnolence diurne excessive et les attaques narcoleptiques, sont fréquemment observés chez les patients Parkinsoniens. Malgré de nombreux efforts cliniques à l’échelle mondiale, il reste à déterminer si ces troubles sont causés par les lésions neuronales dopamine...

Full description

Bibliographic Details
Main Author:	Cendrès-Bozzi, Christophe
Other Authors:	Lyon 1
Language:	fr
Published:	2011
Subjects:	Parkinson Sommeil MPTP Dopamine Agonistes Substance noire Striatum Catécholamines Sleep disorders Dopamin Black substance Catecholamines
Online Access:	http://www.theses.fr/2011LYO10081

Similar Items

The assessment of possible gender-related effect of endogenous striatal alpha-tocopherol level on MPTP neurotoxicity in mice
by: Nikolett Nánási, et al.
Published: (2020-07-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

Insecticide-Mediated Neurochemical and Behavioral Changes as Possible Predisposing Environmental Factors in Idiopathic Parkinson's Disease
by: Kirby, Michael L. Jr.
Published: (2014)

Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
by: Natalie R.S. Goldberg, et al.
Published: (2012-03-01)

A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice
by: Éva M. Szegő, et al.
Published: (2012-01-01)

Dopamine Cell Loss within the Nigrostriatal Pathway Due to Oxidative Stress from Chronic Methylphenidate
by: McWethy, David, et al.
Published: (2019)

Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism
by: Flynn Claudia T, et al.
Published: (2011-07-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Implication de la sérotonine dans l'expression de troubles moteurs et neuropsycho-comportementaux dans la maladie de Parkison
by: Millot, Mathilde
Published: (2019)

Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure
by: Marina Yu. Kopaeva, et al.
Published: (2021-01-01)

Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration
by: Ola Wasel, et al.
Published: (2020-08-01)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
by: St-Amour Isabelle, et al.
Published: (2012-10-01)

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
by: Calon Frédéric, et al.
Published: (2011-10-01)

Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys
by: Mathilde Millot, et al.
Published: (2020-02-01)

Effects of dopamine and serotonin antagonist injections into the striatopallidal complex of asymptomatic MPTP-treated monkeys
by: Sara Neumane, et al.
Published: (2012-10-01)

Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents
by: James G. Greene, et al.
Published: (2010-06-01)

Debunking an old theory
by: Teresa Spix, et al.
Published: (2020-10-01)

Pramipexole impairs stimulus-response learning in healthy young adults
by: Haley Gallant, et al.
Published: (2016-08-01)

The Influence of Long-Term Ritalin Exposure in a Female Model of Parkinson's Disease
by: Phillips, Kaitlyn, et al.
Published: (2021)

A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
by: Chakravarthy, V.S, et al.
Published: (2022)

Amiloride is neuroprotective in an MPTP model of Parkinson's disease
by: Robert L. Arias, et al.
Published: (2008-09-01)

Dérégulation de la dopamine et maladies du repos : maladie de Willis-Ekbom et Maladie de Parkinson
by: Hyacinthe, Carole
Published: (2013)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

What is the true discharge rate and pattern of the striatal projection neurons in Parkinson’s disease and Dystonia?
by: Dan Valsky, et al.
Published: (2020-08-01)

Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson's disease
by: Moonsang Seo, et al.
Published: (2010-08-01)

Neuroimaging studies of striatum in cognition Part II: Parkinson’s disease
by: Alexandru eHanganu, et al.
Published: (2015-10-01)

The tumor suppressor PTEN regulates motor responses to striatal dopamine in normal and Parkinsonian animals
by: Mihaela A. Stavarache, et al.
Published: (2015-10-01)

Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease
by: Karim Fifel, et al.
Published: (2014-11-01)

Current therapy for Parkinson's disease
by: A. V. Obukhova
Published: (2014-10-01)

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients
by: Szász JA, et al.
Published: (2019-04-01)

Adverse drug reaction suggests by a clinical vignette
by: Finestone AJ
Published: (2011-07-01)

In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias
by: Rosario Sánchez-Pernaute, et al.
Published: (2007-08-01)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
by: Chris Vriend, et al.
Published: (2020-01-01)

Many roads to motor deficits: loss of dopamine signaling in direct or indirect basal ganglia pathway leads to akinesia through distinct physiological mechanisms
by: Gwendolyn G Calhoon, et al.
Published: (2010-12-01)

Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease: a potential compensatory role.
by: Hidetaka eKoizumi, et al.
Published: (2013-05-01)

Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
by: William A. Toy, et al.
Published: (2014-03-01)

Dopamine differentially modulates the size of projection neuron ensembles in the intact and dopamine-depleted striatum
by: Marta Maltese, et al.
Published: (2021-05-01)

D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism
by: Bérangère Ballion, et al.
Published: (2009-09-01)

Impaired learning and memory in Pitx3 deficient aphakia mice: A genetic model for striatum-dependent cognitive symptoms in Parkinson's disease
by: Paul Ardayfio, et al.
Published: (2008-09-01)

Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
by: Mohammad Edrees Mohammad, et al.
Published: (2021-01-01)